Statin therapy and bone marrow CD34+ cell frequency in type 2 diabetes mellitus: a cross-sectional study.
Division of Hematology and Endocrinology, Peking University Aerospace Center Hospital, Beijing, China.
Lei
L
Lei
Division of Hematology and Endocrinology, Peking University Aerospace Center Hospital, Beijing, China.
Xiyang
X
Zhang
Department of Cardiology, Peking University First Hospital, Beijing, China; Department of Biochemistry, National Cerebral and Cardiovascular Center, Osaka, Japan. Electronic address: yuanjiemao@gmail.com.
Yuanjie
Y
Mao
Division of Hematology and Endocrinology, Peking University Aerospace Center Hospital, Beijing, China.
Xin
X
Lin
Division of Hematology and Endocrinology, Peking University Aerospace Center Hospital, Beijing, China.
Liyan
L
Yang
Division of Hematology and Endocrinology, Peking University Aerospace Center Hospital, Beijing, China.
Yufang
Y
Li
Division of Hematology and Endocrinology, Peking University Aerospace Center Hospital, Beijing, China.
Song
S
Dong
Division of Hematology and Endocrinology, Peking University Aerospace Center Hospital, Beijing, China. Electronic address: vipwyz@126.com.
Yizhong
Y
Wang
D000328:Adult; D018952:Antigens, CD34 / Q000097:blood*; D016026:Bone Marrow Transplantation / Q000639:trends; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000628:therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D018952:Antigens, CD34; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
Bone marrow stem cells; CD34+; Diabetes mellitus type 2; Statin therapy